Lenalidomide Dr.Reddy's (Lenalidomide)
lenalidomide 5 mg capsule, 21 · ORAL · PBS code 13642B
AUTHORITY_REQUIREDWhat it costs
AU$248.5 PBS-determined price per 21 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2023-10-01.
- • Repeats: 2.
- • PBS program: HS.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Relapsed and/or refractory multiple myeloma
Triple combination therapy consisting of carfilzomib, lenalidomide and dexamethasone
Patient must be undergoing concurrent treatment with carfilzomib obtained through the PBS; AND
Patient must not be undergoing simultaneous treatment with this drug obtained under another PBS listing.
Sponsor: Dr Reddy's Laboratories (Australia) Pty Ltd ABN 16 120 092 408
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.